Healthcare digitization is booming and data-driven innovations are disrupting drug discovery. But we must learn how to use these emerging technologies better so that we can ask more sophisticated questions, and come up with deeper insights into biology and the understanding and treatment of disease. David Shaywitz talks about disruptive innovators and offers some sober views on how hard it is to re-invent drug R&D.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör HBS Kraft Precision Medicine Accelerator. Innehållet i podden är skapat av HBS Kraft Precision Medicine Accelerator och inte av, eller tillsammans med, Poddtoppen.